Propel Bio Management, LLC Compass Pathways PLC Transaction History
Propel Bio Management, LLC
- $172 Billion
- Q3 2024
A detailed history of Propel Bio Management, LLC transactions in Compass Pathways PLC stock. As of the latest transaction made, Propel Bio Management, LLC holds 80,000 shares of CMPS stock, worth $683,199. This represents 0.29% of its overall portfolio holdings.
Number of Shares
80,000Holding current value
$683,199% of portfolio
0.29%Shares
1 transactions
Others Institutions Holding CMPS
# of Institutions
152Shares Held
33.6MCall Options Held
536KPut Options Held
582K-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.41MShares$46.2 Million0.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million4.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.76MShares$32.1 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$17.1 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.61MShares$13.7 Million2.01% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...